2020
DOI: 10.1177/1753466620937170
|View full text |Cite
|
Sign up to set email alerts
|

Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 is a 2019 novel coronavirus, which only in the European area has led to more than 300,000 cases with at least 21,000 deaths. This manuscript aims to speculate that the manipulation of the microbial patterns through the use of probiotics and dietary fibers consumption may contribute to reduce inflammation and strengthen the immune system response in COVID-19 infection. The reviews of this paper are available via the supplemental material section.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
73
0
9

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(82 citation statements)
references
References 52 publications
0
73
0
9
Order By: Relevance
“…The use of prebiotics and probiotics to regulate the balance of the intestinal flora could be an effective treatment to reduce the risk of bacterial and viral infections. 143 It would also be useful to investigate the effect of high-fiber diets and/or probiotics on the outcome of SARS-CoV-2 infection. Design treatments for COVID-19 would be based on the administration of both probiotics and prebiotics, or nutrients that would replace the absent bacteria, thus preventing the risk of systemi infection.…”
Section: Gut Microbiota-based Approaches To Reduced Severity Of the Cmentioning
confidence: 99%
“…The use of prebiotics and probiotics to regulate the balance of the intestinal flora could be an effective treatment to reduce the risk of bacterial and viral infections. 143 It would also be useful to investigate the effect of high-fiber diets and/or probiotics on the outcome of SARS-CoV-2 infection. Design treatments for COVID-19 would be based on the administration of both probiotics and prebiotics, or nutrients that would replace the absent bacteria, thus preventing the risk of systemi infection.…”
Section: Gut Microbiota-based Approaches To Reduced Severity Of the Cmentioning
confidence: 99%
“…This alteration modifies the composition of the intestinal microbiota both qualitatively and quantitatively. In turn, this influences the gut/pulmonary crosstalk [ 14 , 18 , [21] , [22] , [23] , [24] ].…”
Section: The Sars-covid-19 Action On Microbiotamentioning
confidence: 99%
“…In fact, one of the main pathogenic mechanisms causing pulmonary acute damage is the “cytokine storm”. IL-6 is one of the main pro-inflammatory markers in this sense [ 9 , 18 , 24 , 25 ].…”
Section: The Sars-covid-19 Action On Microbiotamentioning
confidence: 99%
“… S.No Study Title Article Type Refs. 1 Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection Review [ 157 ] 2 Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives Review [ 158 ] 3 Traditional Chinese medicine for COVID-19 treatment Review [ 159 ] 4 Gut microbiota and Covid-19- possible link and implications Review [ 160 ] 5 Probiotics and COVID-19 : one size does not fit all Review [ 161 ] 6 Potential Effects Immunomodulators on Probiotics in COVID-19 Preventing Infection in the Future. A Narrative Review Review [ 162 ] 7 The small intestine, an underestimated site of SARS-CoV-2 infection: from Red Queen effect to probiotics Review [ 60 ] 8 Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles Review [ 163 ] 9 Antiviral effects of probiotic metabolites on COVID-19 Express Communication [ 164 ] 10 Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic ...…”
Section: Recent Evidence Of Probiotics In Covid-19 - Preclinical Andmentioning
confidence: 99%